RNU6-570P

Across TCGA pan-cancer cohorts, RNU6-570P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RNU6-570P data layer.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher RNU6-570P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-570P expression acts as an unfavorable survival marker, although some lineages such as LIHC and KIRC show a favorable association.

ESCA, STAD, and THCA are the cancer types where RNU6-570P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Quartile	II,III,IV	0.533	0.759	.001	64	view →
STAD	DFS	Quartile	II,III,IV	0.221	0.605	.002	44	view →
THCA	OS	Tertile	II,III,IV	0.609	0.838	.010	12	view →
LUAD	DFS	Tertile	III,IV	0.121	0.684	<.001	9	view →
SKCM	OS	Tertile	IV	0.415	0.861	.014	9	view →
LIHC	OS	Median	III,IV	0.582	0.221	.018	8	view →
KIRC	DFS	Tertile	IV	0.764	0.465	.034	6	view →
COAD	DFS	Tertile	All	0.660	0.795	.034	6	view →
SARC	OS	Tertile	All	0.751	0.445	.048	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

RNU6-570P–ESCA (OS)

Open the ESCA breakdown →